Streetbeat News

Regulatory

DWAC

Trump Media & Technology Group has announced that the SEC has declared the amended Form S-1 effective.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:25 pm

BTCUSD

DOGEUSD

ETHUSD

SHIBUSD

SOLUSD

Cryptocurrency markets are experiencing a downturn, with notable declines in Bitcoin, Ethereum, and Dogecoin. Despite this, some traders remain optimistic about the future. Key developments include Hashdex filing for a combined Bitcoin and Ethereum ETF, and Paris Match converting photos into Ethereum NFTs. Significant liquidations and large transaction volumes are also noted.

Portfolio Pulse from Khyathi Dalal

June 18, 2024 | 8:24 pm

BCYC

Bicycle Therapeutics has filed a prospectus supplement with the SEC regarding the resale of shares by selling securityholders.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:23 pm

FBLG

FibroBiologics has filed a prospectus with the SEC for the resale of up to 16 million shares of common stock by GEM.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:16 pm

CRLBF

CURLF

GTBIF

MSOS

TCNNF

VRNOF

The U.S. cannabis market presents a significant investment opportunity, particularly for multi-state operators (MSOs) like Green Thumb Industries, Curaleaf, Trulieve, Verano, and Cresco. Despite current market volatility and challenges, the potential rescheduling of cannabis and the passage of the SAFER Banking Act could drive substantial growth. The AdvisorShares Pure US Cannabis ETF (MSOS) includes these key players, which are well-positioned for long-term growth.

Portfolio Pulse from Javier Hasse

June 18, 2024 | 8:11 pm

AKLI

Akili announces that EndeavorOTC is the only FDA-authorized digital therapeutic for ADHD available without a prescription. This product aims to improve attention function in individuals with ADHD through a video game experience.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:10 pm

AKLI

Akili has received FDA clearance for EndeavorOTC (AKL-T01) as an over-the-counter treatment for adults with Attention-deficit/Hyperactivity Disorder (ADHD).

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:02 pm

RDHL

RedHill Biopharma has received a Notice of Allowance for its U.S. Patent Application 17/900,235, titled 'BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)'.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:58 pm

NXL

Nexalin Technology shares are trading higher after the company was awarded a US patent on 'Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimer's and Dementia.'

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:56 pm

NXL

Nexalin Technology has been awarded U.S. Patent #12011591 for its transcranial alternating current dynamic frequency stimulation (TACS) method, aimed at treating Alzheimer's and Dementia.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:52 pm